[Eco-pharma research aimed at developing COVID-19 therapeutic agent].
Nihon Yakurigaku Zasshi
; 157(2): 119-123, 2022.
Article
in Ja
| MEDLINE
| ID: mdl-35228443
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19 Drug Treatment
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
Ja
Journal:
Nihon Yakurigaku Zasshi
Year:
2022
Document type:
Article
Country of publication:
Japón